BS

Balwant Singh

Active Director Director DIN 10194216
DIN 10194216 First appointment Jun 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Balwant Singh

Data last updated:

Balwant Singh is a Director at Dycem Biotech Private Limited (since 2023). Dycem Biotech Private Limited reported revenue of ₹2 Lakh (FY 2024).

DIN 10194216
Primary Designation Director
First Appointment 06 Jun 2023
Oldest Company Age 3 yrs
Largest company Dycem Biotech Private Limited · ₹2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dycem Biotech Private Limited U46497CH2023PTC045117
Director06 Jun 20232023₹2 Lakh (FY 2024)Active

Board colleagues of Balwant Singh

NameDINCompanyDesignation
Anu Rani10194215Dycem Biotech Private LimitedDirector
Jitender Singh10194214Dycem Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dycem Biotech Private Limited
Premium access

Shareholding and investment profile for Balwant Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balwant Singh

Balwant Singh currently holds 1 directorship: Dycem Biotech Private Limited (Director, since 06 Jun 2023, revenue ₹2 Lakh (FY 2024)).

Balwant Singh was first appointed on 06 Jun 2023 as Director at Dycem Biotech Private Limited.

The current boards of Balwant Singh's companies include Anu Rani (Dycem Biotech Private Limited), Jitender Singh (Dycem Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available